Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 2/20 | 0.42 |
| ▸ | PHGDH | O43175 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | MC4R | P32245 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL565222 | 1.00 | CYP1A2 (0.47) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL1069 | 1.00 | — | — | |
| SCHEMBL8629808 | 1.00 | — | — | |
| SCHEMBL7571225 | 1.00 | CYP1A2 (0.47) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL151183 | 1.00 | CYP1A2 (0.47) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL23495473 | 0.94 | CYP1A2 (0.44) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL30952356 | 0.94 | CYP1A2 (0.44) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL17669716 | 0.94 | CYP1A2 (0.44) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL7562588 | 0.94 | CYP1A2 (0.44) | CYP1A2TDP1MGLLPHGDHNCF1 | |
| SCHEMBL7197668 | 0.94 | CYP1A2 (0.44) | CYP1A2TDP1MGLLPHGDHNCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874727-A | Barium complex and preparation method and application thereof | 中国科学院赣江创新研究院 | 2025-04-25 | — | — | CN | claimed |
| CN-116082260-B | Catalyst, preparation method thereof and preparation method of aliphatic isocyanate polymer | 山东新和成精化科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-117117331-A | Alkali metal sulfur battery electrolyte, preparation method thereof and alkali metal sulfur secondary battery comprising same | 天津工业大学 | 2023-11-24 | — | — | CN | claimed |
| CN-116082260-A | Catalyst, preparation method thereof and preparation method of aliphatic isocyanate polymer | 山东新和成精化科技有限公司 | 2023-05-09 | — | — | CN | claimed |
| US-20220396595-A1 | A METAL COMPLEX AND USE THEREOF | RHODIA OPERATIONS (FR) | 2022-12-15 | — | — | US | claimed |
| CN-114599772-A | Metal complexes and their use | 罗地亚经营管理公司 | 2022-06-07 | — | — | CN | claimed |
| EP-2661473-B1 | ANTISKINNING COMPOSITIONS | OMG UK TECH LIMITED (GB) | 2021-09-15 | — | — | EP | claimed |
| CN-107709658-B | Oxidation process | 卡特克塞尔科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| EP-3307941-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| EP-3307940-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| US-20140155525-A1 | LIQUID HARDENING | OMG UK TECHNOLOGY LTD. (GB) | 2014-06-05 | — | — | US | claimed |
| US-20130331487-A1 | ANTISKINNING COMPOSITIONS | OMG UK TECHNOLOGY LIMITED (GB) | 2013-12-12 | — | — | US | claimed |
| US-8497314-B2 | Liquid hardening | OMG UK TECHNOLOGY LTD. (GB) | 2013-07-30 | — | — | US | claimed |
| US-20130123452-A1 | CURING LIQUIDS | OMG ADDITIVES LIMITED (UK) | 2013-05-16 | — | — | US | claimed |
| US-20130041077-A1 | LIQUID HARDENING | OMG UK TECHNOLOGY LTD. (GB) | 2013-02-14 | — | — | US | claimed |
| EP-2474578-A1 | Antiskinning compositions | Rahu Catalytics Limited (GB) | 2012-07-11 | — | — | EP | claimed |
| EP-2343336-A1 | Curing liquids | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) | 2011-07-13 | — | — | EP | claimed |
| EP-2038356-B1 | LIQUID HARDENING | UNILEVER PLC (GB) | 2010-08-11 | — | — | EP | claimed |
| US-20090253833-A1 | Liquid Hardening | OMG UK TECHNOLOGY LTD (GB) | 2009-10-08 | — | — | US | claimed |
| US-5667690-A | Process for removing noxious compounds | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST - NATUURWETENSCHAPPELIJK (NL) | 1997-09-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396595-A1 | A METAL COMPLEX AND USE THEREOF | SOD1, MPO, GPX4 | CYP1A2 3371/4885TDP1 3532/4885MGLL 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.